Efavirenz and CYP2B6 polymorphism:: Implications for drug toxicity and resistance

被引:38
作者
Nolan, D
Phillips, E
Mallal, S
机构
[1] Murdoch Univ, Ctr Clin Immunol & Biomed Stat, Royal Perth Hosp, Perth, WA 6000, Australia
[2] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1086/499369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:408 / 410
页数:3
相关论文
共 13 条
[1]   The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P4502B6 exhibits alterations in substrate metabolism and inactivation [J].
Bumpus, NN ;
Sridar, C ;
Kent, UM ;
Hollenberg, PF .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (06) :795-802
[2]   Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo [J].
Colombo, S ;
Soranzo, N ;
Rotger, M ;
Sprenger, R ;
Bleiber, G ;
Furrer, H ;
Buclin, T ;
Goldstein, D ;
Décosterd, L ;
Telenti, A .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (09) :599-608
[3]   Pharmacogenomics: Translating functional genomics into rational therapeutics [J].
Evans, WE ;
Relling, MV .
SCIENCE, 1999, 286 (5439) :487-491
[4]   Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice? [J].
Gardiner, SJ ;
Begg, EJ .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (05) :365-369
[5]  
Haas DW, 2004, AIDS, V18, P2391
[6]   Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity [J].
Martin, AM ;
Nolan, D ;
Gaudieri, S ;
Phillips, E ;
Mallal, S .
PHARMACOGENOMICS, 2004, 5 (06) :643-655
[7]   Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: An adult AIDS clinical trials group study [J].
Ribaudo, HJ ;
Haas, DW ;
Tierney, C ;
Kim, RB ;
Wilkinson, GR ;
Gulick, RM ;
Clifford, DB ;
Marzolini, C ;
Fletcher, CV ;
Tashima, KT ;
Kuritzkes, DR ;
Acosta, EP .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) :401-407
[8]   Pharmacogenetics and the practice of medicine [J].
Roses, AD .
NATURE, 2000, 405 (6788) :857-865
[9]  
SALIQ ST, 2005, AIDS, V19, P1716